118 related articles for article (PubMed ID: 15643111)
1. Assessment of patient preference and side effects in patients switched from divalproex sodium delayed release to divalproex sodium extended release.
Minirth FB; Neal V
J Clin Psychopharmacol; 2005 Feb; 25(1):99-101. PubMed ID: 15643111
[No Abstract] [Full Text] [Related]
2. Safety and efficacy of switching psychiatric patients from a delayed-release to an extended-release formulation of divalproex sodium.
Horne RL; Cunanan C
J Clin Psychopharmacol; 2003 Apr; 23(2):176-81. PubMed ID: 12640219
[TBL] [Abstract][Full Text] [Related]
3. Extended-release divalproex sodium for mood stabilization.
Stoner SC; Dubisar BM; Lea JW; Marken PA; Ramlatchman LV; Reynolds JB
Pharmacotherapy; 2004 Sep; 24(9):1147-53. PubMed ID: 15460175
[TBL] [Abstract][Full Text] [Related]
4. Extended-release divalproex sodium for patients with side effects from delayed-release divalproex sodium.
Longo LP
Am J Psychiatry; 2005 Aug; 162(8):1548-9. PubMed ID: 16055790
[No Abstract] [Full Text] [Related]
5. Randomized, double-blind, placebo-controlled study of divalproex extended release loading monotherapy in ambulatory bipolar spectrum disorder patients with moderate-to-severe hypomania or mild mania.
McElroy SL; Martens BE; Creech RS; Welge JA; Jefferson L; Guerdjikova AI; Keck PE
J Clin Psychiatry; 2010 May; 71(5):557-65. PubMed ID: 20361901
[TBL] [Abstract][Full Text] [Related]
6. Long-term safety of divalproex sodium extended-release in children and adolescents with bipolar I disorder.
Redden L; DelBello M; Wagner KD; Wilens TE; Malhotra S; Wozniak P; Vigna NV; Greco N; Kovacs X; Abi-Saab W; Saltarelli M;
J Child Adolesc Psychopharmacol; 2009 Feb; 19(1):83-9. PubMed ID: 19232026
[TBL] [Abstract][Full Text] [Related]
7. A randomized, placebo-controlled, multicenter study of divalproex sodium extended-release in the acute treatment of mania.
Hirschfeld RM; Bowden CL; Vigna NV; Wozniak P; Collins M
J Clin Psychiatry; 2010 Apr; 71(4):426-32. PubMed ID: 20361904
[TBL] [Abstract][Full Text] [Related]
8. Efficacy and tolerability of divalproex extended release in psychiatric patients.
Jackson RS; Venkataraman S; Atkins RB; Owens M
Ann Clin Psychiatry; 2006; 18(4):273-4. PubMed ID: 17162629
[No Abstract] [Full Text] [Related]
9. A naturalistic comparison of adverse effects between slow titration and loading of divalproex sodium in psychiatric inpatients.
Lima WJ; Dopheide JA; Kramer BA; Earhart CA; Wincor MZ
J Affect Disord; 1999; 52(1-3):261-7. PubMed ID: 10357044
[TBL] [Abstract][Full Text] [Related]
10. Divalproex sodium as a treatment for borderline personality disorder.
Wilcox JA
Ann Clin Psychiatry; 1995 Mar; 7(1):33-7. PubMed ID: 8541935
[TBL] [Abstract][Full Text] [Related]
11. Divalproex versus valproate in patients with bipolar disorder.
Kablinger AS; Czerwinski WP; Minagar A
J Clin Psychopharmacol; 2004 Apr; 24(2):231-2. PubMed ID: 15206673
[No Abstract] [Full Text] [Related]
12. Treatment of schizoaffective disorder with divalproex sodium.
DelBello MP; Lopez-Larson MP; Getz GE; Strakowski SM
Schizophr Res; 2000 Nov; 46(1):77-9. PubMed ID: 11099889
[No Abstract] [Full Text] [Related]
13. Drug-Drug Interaction Studies of Paliperidone and Divalproex Sodium Extended-Release Tablets in Healthy Participants and Patients with Psychiatric Disorders.
Remmerie B; Ariyawansa J; De Meulder M; Coppola D; Berwaerts J
J Clin Pharmacol; 2016 Jun; 56(6):683-92. PubMed ID: 26412032
[TBL] [Abstract][Full Text] [Related]
14. Rapid oral loading of extended release divalproex in patients with acute mania.
Miller BP; Perry W; Moutier CY; Robinson SK; Feifel D
Gen Hosp Psychiatry; 2005; 27(3):218-21. PubMed ID: 15882770
[TBL] [Abstract][Full Text] [Related]
15. Dosing of divalproex extended release.
Feifel D
J Clin Psychiatry; 2007 Jul; 68(7):1146-7; author reply 1147. PubMed ID: 17685756
[No Abstract] [Full Text] [Related]
16. Stuttering as a side-effect of divalproex sodium.
Aukst-Margetić B; Margetić B
Psychiatry Clin Neurosci; 2008 Dec; 62(6):748. PubMed ID: 19068016
[No Abstract] [Full Text] [Related]
17. Clinical comparison of extended-release divalproex versus delayed-release divalproex: pooled data analyses from nine trials.
Smith MC; Centorrino F; Welge JA; Collins MA
Epilepsy Behav; 2004 Oct; 5(5):746-51. PubMed ID: 15380129
[TBL] [Abstract][Full Text] [Related]
18. Pilot comparison of extended-release and standard preparations of divalproex sodium in patients with bipolar and schizoaffective disorders.
Centorrino F; Kelleher JP; Berry JM; Salvatore P; Eakin M; Fogarty KV; Fellman V; Baldessarini RJ
Am J Psychiatry; 2003 Jul; 160(7):1348-50. PubMed ID: 12832255
[TBL] [Abstract][Full Text] [Related]
19. Paliperidone extended-release as adjunctive therapy to lithium or valproate in the treatment of acute mania: a randomized, placebo-controlled study.
Berwaerts J; Lane R; Nuamah IF; Lim P; Remmerie B; Hough DW
J Affect Disord; 2011 Mar; 129(1-3):252-60. PubMed ID: 20947174
[TBL] [Abstract][Full Text] [Related]
20. Long-term outcome with divalproex in children and adolescents with bipolar disorder.
Henry CA; Zamvil LS; Lam C; Rosenquist KJ; Ghaemi SN
J Child Adolesc Psychopharmacol; 2003; 13(4):523-9. PubMed ID: 14977465
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
